Hypertrophy

Citations 371-380 of 685 total displayed.

Past content (since Mar 1999):

Part 2 Original Articles
Early Endothelin-A Receptor Blockade Decreases Blood Pressure and Ameliorates End-Organ Damage in Homozygous Ren-2 Rats

Ivana Vanêcková, Herbert J. Kramer, Angela Bäcker, Zdena Vernerová, Martin Opocensky, and Ludêk Cervenka
Hypertension 2005;46:969-974; published online before print as doi:10.1161/01.HYP.0000173426.06832.b5 [Abstract] [Full text]  

Scientific Contributions
Nicorandil Promotes Myocardial Capillary and Arteriolar Growth in the Failing Heart of Dahl Salt-Sensitive Hypertensive Rats

Jinglan Xu, Kohzo Nagata, Koji Obata, Sahoko Ichihara, Hideo Izawa, Akiko Noda, Tetsuro Nagasaka, Mitsunori Iwase, Tomoki Naoe, Toyoaki Murohara, and Mitsuhiro Yokota
Hypertension published September 19, 2005, doi:10.1161/01.HYP.0000185189.46698.15 [Abstract]  

Scientific Contributions
Vascular Hypertrophy in Angiotensin II-Induced Hypertension Is Mediated by Vascular Smooth Muscle Cell-Derived H₂O₂

Yong Zhang, Kathy K. Griendling, Anna Dikalova, Gary K. Owens, and W. Robert Taylor
Hypertension published September 19, 2005, doi:10.1161/01.HYP.0000182660.74266.6d [Abstract]  

Scientific Contributions
Early Endothelin-A Receptor Blockade Decreases Blood Pressure and Ameliorates End-Organ Damage in Homozygous Ren-2 Rats

Ivana Vanêcková, Herbert J. Kramer, Angela Bäcker, Zdena Vernerová, Martin Opoensk, and Ludêk Cervenka
Hypertension published September 12, 2005, doi:10.1161/01.HYP.0000173426.06832.b5 [Abstract]  

Editorial Commentaries
Potassium Depletion and Cardiac Hypertrophy: How Does It Work?

Joseph I. Shapiro
Hypertension 2005;46:477-478, doi:10.1161/01.HYP.0000178605.15028.ba [Full text]  

Original Articles
Cardiovascular Morbidity and Mortality in Hypertensive Patients With Lower Versus Higher Risk: A LIFE Substudy

Stanley S. Franklin, Kristian Wachtell, Vasilios Papademetriou, Michael H. Olsen, Richard B. Devereux, Frej Fyhrquist, Hans Ibsen, Sverre E. Kjeldsen, and Björn Dahlöf
Hypertension 2005;46:492-499; published online before print as doi:10.1161/01.HYP.0000179604.42845.8d [Abstract] [Full text]  

Original Articles
Potassium Supplementation Reduces Cardiac and Renal Hypertrophy Independent of Blood Pressure in DOCA/Salt Mice

Qing Wang, Andrea A. Domenighetti, Thierry Pedrazzini, and Michel Burnier
Hypertension 2005;46:547-554; published online before print as doi:10.1161/01.HYP.0000178572.63064.73 [Abstract] [Full text]  

Original Articles
Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats

Bernhard Pilz, Erdenechimeg Shagdarsuren, Maren Wellner, Anette Fiebeler, Ralf Dechend, Petra Gratze, Silke Meiners, David L. Feldman, Randy L. Webb, Ingrid M. Garrelds, A.H. Jan Danser, Friedrich C. Luft, and Dominik N. Müller
Hypertension 2005;46:569-576; published online before print as doi:10.1161/01.HYP.0000179573.91016.3f [Abstract] [Full text]  

Scientific Contributions
Cardiovascular Morbidity and Mortality in Hypertensive Patients With Lower Versus Higher Risk. A LIFE Substudy

Stanley S. Franklin, Kristian Wachtell, Vasilios Papademetriou, Michael H. Olsen, Richard B. Devereux, Frej Fyhrquist, Hans Ibsen, Sverre E. Kjeldsen, and Björn Dahlöf
Hypertension published August 22, 2005, doi:10.1161/01.HYP.0000179604.42845.8d [Abstract]  

Scientific Contributions
Aliskiren, a Human Renin Inhibitor, Ameliorates Cardiac and Renal Damage in Double-Transgenic Rats

Bernhard Pilz, Erdenechimeg Shagdarsuren, Maren Wellner, Anette Fiebeler, Ralf Dechend, Petra Gratze, Silke Meiners, David L. Feldman, Randy L. Webb, Ingrid M. Garrelds, A. H. Jan Danser, Friedrich C. Luft, and Dominik N. Müller
Hypertension published August 15, 2005, doi:10.1161/01.HYP.0000179573.91016.3f [Abstract]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69